Your session is about to expire
← Back to Search
Alcohol Response for Bipolar Disorder (Long_BACS Trial)
N/A
Recruiting
Led By Elizabeth Lippard, PhD
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Summary
This trial will look at how stress, childhood maltreatment, and brain development affect the risk of developing alcohol use disorders in people with bipolar disorder. It will involve 160 people, half with bipolar disorder, and study their brain development and response to alcohol over two years.
Who is the study for?
This study is for young adults aged 21-26, both with bipolar disorder and typical development. Participants must have had a certain level of alcohol use in the past year but not severe alcohol use disorders or other significant medical conditions. They should be stable on medications if any, and able to undergo MRI scans.
What is being tested?
The trial investigates how individuals with bipolar disorder respond to alcohol compared to a placebo beverage. It aims to understand biological risk factors for developing alcohol misuse by using neuroimaging techniques over two years.
What are the potential side effects?
While the study involves consuming alcohol, potential side effects are not detailed; however, common reactions may include impaired judgment, coordination issues, mood changes, and hangover symptoms like headache or nausea.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Neural trajectories associated with subjective response to alcohol
Relations between changes in subjective response and associated neural trajectories with alcohol misuse and problems at two-year follow-up
Relations between changes in subjective response and associated neural trajectories with alcohol use disorder symptoms at two-year follow-up
+1 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: AlcoholActive Control1 Intervention
Participants will be provided alcohol during study visits and changes in behavior/neural activity after consuming alcohol will be examined.
Group II: PlaceboPlacebo Group1 Intervention
placebo beverage condition
Find a Location
Who is running the clinical trial?
University of Texas at AustinLead Sponsor
375 Previous Clinical Trials
86,195 Total Patients Enrolled
5 Trials studying Bipolar Disorder
194 Patients Enrolled for Bipolar Disorder
Elizabeth Lippard, PhDPrincipal InvestigatorUniversity of Texas at Austin
3 Previous Clinical Trials
328 Total Patients Enrolled
2 Trials studying Bipolar Disorder
128 Patients Enrolled for Bipolar Disorder
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of heart issues, high blood pressure, diabetes, or liver disease.I have had a significant head injury with unconsciousness for 5 minutes or more.I have never been hospitalized for psychiatric reasons.I have taken psychotropic medication for no more than 1 month in my life.I am unwilling to arrange for someone to drive me home after alcohol sessions.I have been on stable medication for my bipolar disorder for at least 4 weeks.I have not had more than 3 (if woman) or 4 (if man) drinks in one day in the past year.I am between 21 and 26 years old.I have never been diagnosed with a neurodevelopmental, mood, psychotic, or eating disorder.I have been diagnosed with bipolar disorder by a structured interview.
Research Study Groups:
This trial has the following groups:- Group 1: Placebo
- Group 2: Alcohol
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger